Effects of menstrual cycle and oral contraceptive use on calf venous compliance

2005 ◽  
Vol 288 (1) ◽  
pp. H103-H110 ◽  
Author(s):  
Jessica R. Meendering ◽  
Britta N. Torgrimson ◽  
Belinda L. Houghton ◽  
John R. Halliwill ◽  
Christopher T. Minson

Numerous studies have shown that the female sex hormones estrogen and progesterone have multiple effects on the vasculature. Thus our goal was to investigate the effects of estrogen and progesterone on calf venous compliance by looking for cyclic changes during the early follicular, ovulatory, and midluteal phases of the menstrual cycle and during high and low hormone phases of oral contraceptive use. Additionally, we wanted to compare the venous compliance of normally menstruating women, oral contraceptive users, and men. We studied eight normally menstruating women (23 ± 1 yr of age) during the early follicular, ovulatory, and midluteal phases of the menstrual cycle. Nine triphasic oral contraceptive users (21 ± 1 yr of age) were studied during weeks of high and low hormone concentrations. Eight men (23 ± 1 yr of age) were studied twice within 2–4 wk. With the use of venous occlusion plethysmography with mercury in-Silastic strain gauges, lower limb venous compliance was measured by inflating a venous collection cuff that was placed on the thigh to 60 mmHg for 8 min and then reducing the pressure to 0 mmHg at a rate of 1 mmHg/s. Venous compliance was calculated as the derivative of the pressure-volume curves. There were no differences between early follicular, ovulatory, and midluteal phases of the menstrual cycle or between high and low hormone phases of oral contraceptive use ( P > 0.05). Male venous compliance was significantly greater than in normally menstruating women ( P < 0.001) and oral contraceptive users ( P < 0.002). These data support a sex difference but also suggest that venous compliance does not change with menstrual cycle phase or during the course of oral contraceptive use.

2011 ◽  
Vol 25 (6) ◽  
pp. 1571-1578 ◽  
Author(s):  
Sille Vaiksaar ◽  
Jaak Jürimäe ◽  
Jarek Mäestu ◽  
Priit Purge ◽  
Svetlana Kalytka ◽  
...  

Neurology ◽  
2009 ◽  
Vol 72 (10) ◽  
pp. 911-914 ◽  
Author(s):  
A. G. Herzog ◽  
A. S. Blum ◽  
E. L. Farina ◽  
X. E. Maestri ◽  
J. Newman ◽  
...  

2005 ◽  
Vol 98 (5) ◽  
pp. 1720-1731 ◽  
Author(s):  
Kevin A. Jacobs ◽  
Gretchen A. Casazza ◽  
Sang-Hoon Suh ◽  
Michael A. Horning ◽  
George A. Brooks

We evaluated the hypothesis that fatty acid reesterification would be increased during rest and exercise in the midluteal menstrual cycle phase and during oral contraceptive use, when ovarian hormone concentrations are high, compared with the early follicular phase. Subjects were eight moderately active, weight-stable, eumenorrheic women (24.8 ± 1.2 yr, peak oxygen consumption = 42.0 ± 2.3 ml·kg−1·min−1) who had not taken oral contraceptives for at least 6 mo. Plasma free fatty acid (FFA) kinetics were assessed in the 3-h postprandial state by continuous infusion of [1-13C]palmitate and [1,1,2,3,3-2H]glycerol during 90 min of rest and 60 min of exercise at 45% and 65% peak oxygen consumption in the early follicular and midluteal menstrual cycle phases and during the inactive- and high-dose phases following 4 mo of oral contraceptive use. Plasma FFA rates of appearance, disappearance, and oxidation increased significantly from rest to exercise with no differences noted between menstrual cycle or oral contraceptive phases or exercise intensities. Compared with either menstrual cycle phase, oral contraceptive use resulted in an increase in plasma-derived fatty acid reesterification and a decrease in the proportion of plasma FFA rate of disappearance that was oxidized at rest and during exercise. Endogenous and exogenous synthetic ovarian hormones do not exert a measurable influence on plasma FFA turnover or oxidation at rest or during moderate-intensity exercise in the 3-h postprandial state when carbohydrate use predominates. The increase in whole body lipolytic rate during exercise noted previously with oral contraceptive use is not matched by an increase in fatty acid oxidation and results in an increase in reesterification. Synthetic ovarian hormones contained in oral contraceptives increase lipolytic rate, but fatty acid oxidation during exercise is determined by exercise intensity and its metabolic and endocrine consequences.


Sign in / Sign up

Export Citation Format

Share Document